A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)

被引：0

作者：

Kelly, W

O'Connor, O

Richon, VM

Tong, W

Rao, TD

Chiao, J

O'Brien, JP

Rifkid, RA

Marks, PA

Scher, HI

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Pharmacol, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Cell Biol, New York, NY 10021 USA

[4] Aton Pharma Inc, Tarrytown, NY USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

286

引用

页码：S88 / S88

页数：1